Aiken, SC, United States of America

Paul Cross


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Paul Cross

Introduction

Paul Cross is an accomplished inventor based in Aiken, South Carolina. He has made significant contributions to the field of chemical analysis, particularly in the production and quality control of sevoflurane, a commonly used anesthetic. His innovative approach has led to the development of a patented method that enhances the efficiency and safety of sevoflurane production.

Latest Patents

Paul Cross holds a patent for a "Chromatographic method for the analysis of both in process and finished sevoflurane." This method allows for the separation, identification, and quantification of organic matter found in crude sevoflurane using specialized gas chromatographic columns. The patent also outlines a process control method for the production of sevoflurane, which includes steps for extracting, cooling, and distilling the mixture to isolate the sevoflurane effectively. Additionally, it provides a method for determining the impurity level of purified sevoflurane, ensuring its safety for use in human and animal anesthesia.

Career Highlights

Paul Cross is associated with Halocarbon Products Corporation, where he applies his expertise in chemical engineering and analysis. His work has been instrumental in advancing the production processes of sevoflurane, contributing to the overall improvement of anesthetic safety and efficacy.

Collaborations

Throughout his career, Paul has collaborated with notable colleagues, including Barry Malcolm Jones and Ashot Khrimian. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of chemical analysis.

Conclusion

Paul Cross's contributions to the field of anesthetic production through his patented methods demonstrate his commitment to innovation and safety in medical practices. His work continues to impact the industry positively, ensuring that sevoflurane remains a reliable option for anesthesia.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…